Lexicon Pharmaceuticals (LXRX) Current Deferred Revenue (2010 - 2025)
Lexicon Pharmaceuticals (LXRX) reported Current Deferred Revenue of $4.3 million for Q3 2025, down 75.35% quarter-over-quarter from $17.5 million in Q2 2025.
Lexicon Pharmaceuticals (LXRX) Current Deferred Revenue (2010 - 2025) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has 11 years of Current Deferred Revenue data on file, last reported at $4.3 million in Q3 2025.
- Current Deferred Revenue for Q3 2025 came in at $4.3 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was $4.3 million (changed N/A YoY), and the FY2018 annual result was $2.3 million, down 94.2% from the prior year.
- Current Deferred Revenue slipped to $4.3 million in Q3 2025 per LXRX's latest filing, from $17.5 million in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $45.0 million in Q1 2025 and troughed at $4.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Lexicon Pharmaceuticals | 804.48 Mn | 633.82 Mn | 20.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 4.30 Mn |
| Jun 30, 2025 | 17.46 Mn |
| Mar 31, 2025 | 45.00 Mn |
| Sep 30, 2019 | 1.12 Mn |
| Jun 30, 2019 | 2.24 Mn |
| Mar 31, 2019 | 2.43 Mn |
| Dec 31, 2018 | 2.34 Mn |
| Sep 30, 2018 | 2.12 Mn |
| Jun 30, 2018 | 5.12 Mn |
| Mar 31, 2018 | 7.44 Mn |
| Dec 31, 2017 | 40.35 Mn |
| Sep 30, 2017 | 48.74 Mn |
| Jun 30, 2017 | 63.20 Mn |
| Mar 31, 2017 | 69.17 Mn |
| Dec 31, 2016 | 63.37 Mn |
| Sep 30, 2016 | 78.87 Mn |
| Jun 30, 2016 | 61.53 Mn |
| Mar 31, 2016 | 70.76 Mn |
| Dec 31, 2015 | 76.50 Mn |
| Sep 30, 2015 | 1.74 Mn |